Prices will increase between $110 and $130 depending on the dosage after the current U. S. government purchase program expires. Meanwhile, pressure on drugmakers to expand into drugs comes even as Novartis says it will continue production of some generic leukemia drugs.
In the news about pharmaceuticals and drug accessibility —
in trials –
And in industry news –
Thank you for your interest in supporting Kaiser Health News (KHN), the nation’s premier nonprofit newsroom focused on fitness and fitness policy. We distribute our journalism for free and advertising through media partners of all sizes and in communities large and small. bureaucracy of participation of our readers and listeners, and we appreciate your support.
KHN is an independent editorial program of KFF (Kaiser Family Foundation). You can KHN by making a contribution to KFF, a non-profit charity that is not related to Kaiser Permanente.
Click on the button below the KFF donation page that will provide more facts and frequently asked questions. Thank you!